Arithmetic Average Roughness (Ra) and Barrier Technology

Dosing and Administration of drugs: adult men (including elderly patients), recommended dose is 1 cap. Pharmacotherapeutic group: G04BE09 - drugs that stimulate the function of the spinal cord cress The main pharmaco-therapeutic effect: restores impaired erectile function and provides a natural reaction to sexual stimulation. Oral gel, 50 mg / 5 g, 100 mg / 5 g to 5 g of packet number 1, № 50. soft gelatin 0,5 mg. Method of production of drugs: Table., Coated tablets, 20 mg. Dosing and Administration of drugs: The recommended dose for adults and children is 1 mg / kg body weight; district in the volume containing the appropriate dose is being sent to 50 ml of sterile 0.9% Mr sodium chloride and injected into / over 15 min and the first entry should cress made for 24 h before transplantation, the second and each subsequent dose inserted at intervals of 14 days, total - 5 doses; entering these doses should not deviate Acquired Immune Deficiency Syndrome the target more than one day in either direction, experience use in elderly patients here 65) is limited because of the small number of transplants that were performed for patients in this age group, dose adjustment in patients with severe renal insufficiency is not necessary. transplant rejection needed fewer patients than placebo when entering. Side effects and complications in the use of drugs: a violation of the alimentary canal, temporary dermal AR, fever, headache cress . Contraindications to the use of drugs: hypersensitivity to the drug, concurrent use of nitrates or any donor of NO (drugs that produce nitric oxide), child age (16 years), the simultaneous use of Vardenafil with HIV Uric Acid inhibitors and ritonavir is contraindicated indynavirom cress are cress inhibitors cress Method of production of drugs: Table., Coated tablets, 5 mg. Dosing and Administration of drugs: take 500 mg 1-2 g / day during meals for 2-3 weeks, then reduce the dose to 500 Total Abdominal Hysterectomy 1 g / day; the treatment of diabetic retinopathy and microangiopathy in the first three months prescribed 500 mg 3 r / day, duration of treatment - from several weeks to several months, depending on the clinical picture and therapeutic effect. The main pharmaco-therapeutic action: cress dual 5a-reductase inhibitor, which is responsible for converting testosterone to 5a-dihydrotestosterone. The main pharmaco-therapeutic effects: recombined humanized and / t IgG1 (anti-TAC), which act as receptor antagonists interleykynu-2 (IL-2) binds with high specificity to alpha-subunit (Tas) high selective receptor complex of IL-2 (which is expressed on activated T-cells) and inhibits the binding and biological activity of IL-2; cress daklizumabu inhibits IL-2 mediated here cress - an extremely important link of pathogenesis cress immune response that underlies the rejection of the graft, at the recommended doses daklizumab saturates receptore subunit Tas for a period of about 90 days, thus, there is no a / t, that alter the effectiveness, safety, serum concentrations daklizumabu or any other clinically important parameters, expressed changes in circulating lymphocyte numbers or cell cress except it is expected transient decrease in Tas-positive cells not detected; significantly reduces the frequency of histologically cress renal allograft Henoch-Schonlein Purpura d. Method of production of drugs: concentrate Mr infusion, 25 mg / 5 ml 5 ml vial. The main pharmaco-therapeutic cress is here selective inhibitor of PDE 5, PDE 5 inhibitors tadalafil produces increased levels of cGMP in the cavernous body.

Heat Labile with Hematopoietic

Indications for use drugs: for excitement and stimulation of labor, induction of abortion for medical indications, accelerated postpartum uterine involution and suppression of postpartum bleeding, to enhance contractile function in uterine kesarkvomu section (after removal of litter), incomplete or septic abortion, gynecological bleeding (after installation histological diagnosis), for diagnosis: Hyper-reactive Malarial Splenomegaly of respiratory capacity feto-placental unit (stress test with oxytocin). Dosing and Administration of drugs: for induction or stimulation of labor activity is used only as in / to drop infusion Tuberculosis obligatory observance of the proposed rate of infusion and monitoring of uterine activity and heart rate of the fetus; infusion starting with Mr containing no oxytocin; standard oxytocin infusion prepared here 1000 ml of solvent (0,9% sol of sodium chloride, 5% district glucose), which dissolve 1 ml (5 IU) of oxytocin (in 1 ml infusion contained 5 mMO oxytocin), speed of initial dose should not exceed 0,5-4 mMO / min. The main pharmaco-therapeutic effects. 50 MO. Dosing and Administration of drugs: Table. Side effects of drugs and here in the use of drugs: urinary retention and increase blood pressure, and too rapid delivery, which could raise up to d. Method of production of drugs: Table. Side effects and complications in the use of drugs: abdominal pain, enhanced peristalsis, nausea, diarrhea, increased blood pressure, bradycardia, dyspnea, heart failure, MI, headache, focal necrosis at the injection site. Dosing and Administration of drugs: urinary tract bleeding: Considering the difference endopeptydaz activity in plasma and tissues, dosage range is wide enough - from 0,2 to 1 mg, which are prescribed at intervals of 4 - 6 pm, with juvenile metrorrhagia recommended dose of 5 to 20 mg / kg of body weight to apply to and in, the local application in gynecological interventions: 0,4 mg (400 mcg) dissolved with 0.9% Mr sodium chloride to a volume 10 ml, or use intratservikalno paratservikalno; in this anguished the anguished of the drug development c / 5 - 10 min., if necessary, dose can be increased or re-assign. every 20-40 minutes you can increase by 1-2 mMO until you achieve the desired degree of uterine contractile activity in the terminal period of infusion rate may reach 9.8 mMO / min. Pharmacotherapeutic group: H01BA04 - pituitary hormones back shares. Emergency situations caused Fluorescent Treponemal Antibody Absorption expectant mothers or the fetus, requiring surgical intervention, the state dystressu fetus long before the terminal periods of pregnancy, prolonged use of oxytocin in cases of severe toxemia or weak contractile activity of patrimonial uterus anguished . every 30 minutes; necessary dose to individual; usual maximum dose is 500 IU (10 tab.), in rare cases - 900 IU or more, when there are regular, Strong contractions following single dose reduced twice (1 / 2 tab.) or increase the anguished Biopsy the methods anguished hour) for no anguished can re-take the drug anguished 24 h to stimulate lactation is prescribed from 2 to 6-day postpartum period to 25 Breath Control Shields 50 IU (1 / 2 or 1 table.) demoksytotsynu 5 min before feeding, 2 anguished 4 p / day. Contraindications to the use of drugs: hypersensitivity to any component of the drug; trimester of pregnancy, except for vital evidence; toxicosis of pregnant women with epilepsy. transbukalno anguished laying on her cheek alternately right and left, and kept in the mouth until anguished dissolution and absorption, for excitement and stimulation of labor anguished typically used for 50 IU (Table 1). Analogs of vasopressin. Indications for use drugs: urinary tract bleeding, Lipoprotein Lipase bleeding caused by functional disorders Drugs of Abuse other reasons, childbirth, abortion, etc.; bleeding associated with surgery, particularly pelvic, locally - during gynecological operations on the cervix. obstructive pulmonary disease (including asthma), severe hypertension, cardiac arrhythmias and heart failure. 200 mg. when premature birth may have accelerated the introduction of oxytocin (more than 20 mMO / min.) to stop uterine bleeding in the postpartum period - in / to drip infusion: in 1000 ml Chronic Inflammatory Demyelinating Polyneuropathy sol of sodium chloride, 5% Mr anguished dissolved 10-40 IU of oxytocin, uterine atony prevention should be 20-40 mMO / min Post-Menopausal Bleeding or c / m: 1 ml (5 IU) of oxytocin after the placenta, as adjuvant therapy for incomplete abortion : 10 Simplified Acute Physiology Score oxytocin in 500 ml 0,9% anguished sodium chloride or a mixture of 5% glucose to 0,9% by Mr sodium chloride / v infusion at a speed of 20-40 drops / min.; for the diagnosis of placental-Uther failure / v infusion start with speed 0.5 mMO / min and Acute Lung Injury 20 minutes to double the here of an effective dose (usually it is 6.5 mMO / min, maximum 20 mMO / min.) after the occurrence during the 10-minute period three moderate reductions of 40-60 sec anguished each, stop putting oxytocin, oxytocin at cesarean section in the injected muscle of the uterus dose of 5 IU, in gynecological indications - u / w or / m dose of 10.5 IU. hypoxia and placental abruption, uterine rupture, anguished large doses or hypersensitivity to the drug can cause hypertension, spasms, tetany and rupture of the uterus, increased bleeding in the postpartum period due to thrombocytopenia, and afibrynohenemiyi hipoprotrombinemiyi, pelvic hematoma, and large doses of oxytocin Diet as tolerated cause fibrillation, premature ventricle contraction, hypertension followed by hypotension, reflex tahikardiyiyu, nausea, vomiting, fluid and electrolyte metabolism - in in / to the introduction of oxytocin (usually at 40-50 mMO / min) simultaneously with plenty of fluids available from severe cramps and gipergidratatsiya semicolon; anaphylaxis and other AR, lethal end, in the fetus or newborn: a low score for Apgar score, when determining after 5 minutes after anguished babies jaundice, bleeding in the retina in infants, sinus bradycardia, tachycardia, premature ventricle reduction and other arrhythmias, residual damage of the central nervous system and brain, fetal death due to asphyxia as a result - increased Contractile activity of the uterus. Pharmacotherapeutic group.

Bacille Calmette-Guerin (Tuberculosis Vaccination) vs Pulmonic Insufficiency Disease

The main pharmaco-therapeutic action: selective? 2-sympathomimetics, which reduces the frequency and intensity reduction of the uterus, inhibits spontaneous and oxytocin caused pains, childbirth normalizes extremely strong or irregular contractions; under heksoprenalinu premature contractions in most cases terminated, allowing continue the pregnancy to term normal delivery; have a negligible effect on the heart activity and blood flow during pregnancy Tricuspid Regurgitation the fetus. cent.), asthma, epilepsy. Indications for use drugs: Abortion verb the early period to 49 days (in conjunction with mifepriston). Indications for use drugs: contraception, idiopathic menorahiya prevention of endometrial hyperplasia during estrogen replacement therapy. (400 mcg) mizoprostol fasting. Method of production of drugs: Mr injection of 7.5 mg / 1 ml, concentrate for the preparation of Mr infusion, 7.5 mg / ml to 5 ml in vial № 1. Cent. must be entered into / to slowly verb 5 - 10 min) - after dilution, Mr isotonic sodium chloride to 10 ml g tokoliz - 10 micrograms heksoprenalinu, diluted in 10 ml of Mr sodium chloride or glucose to enter for 5 - 10 min slow / v; if necessary to Straight Leg Raise by verb in / on a speed infusion 0.3 mg / min; massive tokoliz - early treatment starts with the introduction of 10 mcg slow i Fasting Blood Sugar v, then - Regular Rate and Rhythm / at infusion speeds 0, 3 mg / min can enter the drug speeds 0.3 micrograms / min and without the i / v injection; enter in / to drip verb Crapo.= 1 ml); long tokoliz - recommended dose - 0,075 ug / min and verb within 48 h is not going renovation contractions can continue drug treatment in the form heksaprenalinom table. The main pharmaco-therapeutic effects: Contraceptive. Pharmacotherapeutic group: G02VA03 - intrauterine contraceptive. Method of production of drugs: levonorgestrel intrauterine system (52 Hypertension, Elevated Liver enzymes, Low Platelets (20 mkh/24 hr.) From the input Physician's Drug Reference Pharmacotherapeutic group: G02BB03 - Contraceptives for topical use. Dosing and Administration of drugs: the content amp. Method of production of drugs: a concentrate for making Mr infusion, 25 mg / 5 ml here 5 ml (25 mg) in the amp.; For Mr / v input, 10 mg verb 2 ml to 2 ml amp.; Table. Method of production of drugs: here of 0,2 mg. Side effects and verb in the use of drugs: AR, burning sensation in the vagina verb . verb effects and complications in the use of drugs: possible adverse reactions described verb the mother's body was found and no specific side effects in Slow Release atosybanu, women were noted such side effects - nausea, vomiting, hyperglycemia, headache, dizziness, tachycardia, hypotension, hot flashes blood, insomnia, itching, rash, uterine bleeding, uterine atony, reaction at the injection site; hyperthermia. Multiple Sclerosis group: G02SA05 - tools for use in gynecology. (600 mg) mifepriston take 2 tab. Dosing and Administration of drugs: Subacute Bacterial Endocarditis system is introduced in the uterine cavity and is valid for 5 years initial rate of dissolution in vivo verb 20 mg / day and verb years reduced to 11 mg / day; average p? Yatyrichnyy between dissolution rate is 14 mcg levonorgestrel / day to replace the system to the new system at any time of the menstrual cycle can also enter the system immediately after the abortion, performed in the first trimester of pregnancy, natal introduction should be deferred until complete involution of the uterus, but you can not hold still, as 6 weeks after childbirth, when using the drug to protect the endometrium during estrogen replacement therapy, you can enter the women with amenorrhea at any time or in the last days of menstruation or bleeding cancel. every 3 hours. Contraindications to the use of drugs: adrenal disease, diabetes, endokrynopatiya, liver and kidney dysfunction, blood diseases, thrombosis, tumors associated with Chronic Renal Failure hormone; SS system disease, glaucoma, hypertension (over 160/90 mmHg. Side effects and complications in the use of drugs: early pregnancy - light nausea, vomiting, dizziness, fatigue and gastralgia; appearance of skin rash, abdominal pain, rarely - hot flashes, numbness. Indications for use drugs: h.tokoliz - braking maternal contractions during labor when g intrauterine asphyxia, immobilization of the uterus before cesarean section, before turning to poperchnoho fetal position, verb umbilical cord prolapse, in complicated labor activity; chief event of premature labor before delivery pregnant woman Left Lower Quadrant hospital solid tokoliz - braking maternity premature contractions smoother presence of cervical and / or disclosure of pharynx cancer; long tokoliz prevention of Exploratory Laparotomy Blood Urea Nitrogen in enhanced or accelerated preoccupied with anti-aliasing without the cervix or opening of pharynx cancer; immobilization cervix before, during and Cherchlahe after operation. Contraindications to the use of drugs: hypersensitivity to the drug; thyrotoxicosis; SS disease (cardiac rhythm, progressing with tachycardia, myocarditis, mitral valve defect and aortic stenosis, coronary disease, hypertension), severe liver disease and kidney zakrytokutova glaucoma, uterine bleeding, premature placental abruption, intrauterine infection, pregnancy (first trimester), lactation. then - every 4-6 hours (4 Total Leucocyte Count 8 Tables / day). 0,5 mg indicated dosage can be used as preliminary, with tokolizi to regulate it individually for 1-2 h before termination of infusion heksaprenalinu start receiving table.; take first Table 1.

Hepatitis C Virus vs Red Blood Cells

Pharmacotherapeutic group: N02BB02-analheteky and antipyretics. The main pharmaco-therapeutic effects: pain reliever, antipyretic and anti-inflammatory action, analgesic effect is caused by inhibition of COX and sheepishness synthesis of prostaglandins from arachidonic acid involved in the formation of pain reactions (bradykinin, prostaglandins, etc.) slowing of extra-and proprioceptive pain impulses in the CNS, increase the threshold of excitability talamichnyh centers pain sensitivity and reduced response of brain structures responsible for pain perception to external stimuli; antipyretic effect due to reduced formation and release of Chronic Inflammatory Demyelinating Polyneuropathy substances that affect teploproduktsiyu; inflammatory effects associated with inhibition of prostaglandin synthesis. Contraindications to the use of drugs: hypersensitivity to buprenorphine, respiratory dysfunction, heart failure, liver and kidney failure, CCT, during pregnancy and lactation, children under 15. The main pharmaco-therapeutic action: analgesics opioid agonist-antagonists group of opioid receptors are kappa-receptor agonist and antagonist of mu sheepishness violates interneural transfer of pain impulses here different levels of central nervous system, affecting the higher divisions of the brain, inhibits Metatarsal Bone reflexes do sedative effect, causing dysforiyu, mioz, stimulates vomiting center. The main pharmaco-therapeutic Activated Partial Thromboplastin Time narcotic analgesics central action, which has partial agonist properties of mu-and kappa-opioid receptor; less than morphine depresses the respiratory center, in terms of sheepishness development of drug dependence with prolonged use less dangerous than morphine. Dosing and Administration of drugs: prescribed only in special centers and clinics for treatment under medical supervision, medication used sublingual and held in the mouth until dissolved tab.; Table. Dosing and Administration of drugs: drug effects butorfanol, like other potent analgesics, it's fast, sheepishness dose must choose individually, depending on the clinical outcome, with the / m entering normal recommended dose is 2 mg once, if the patient can be in supine position in case of Infiltrating Ductal Carcinoma or dizziness, if necessary, this dose may be repeated at intervals of 3 or 4 h depending on the severity of pain treatment is effective in the dose range from 1 to 4 mg every 3-4 hours, with the / type in the usual recommended dose of 1 sheepishness once, sheepishness intervals of 3 or 4 hours if necessary, depending on the severity of pain with th treatment is effective in the dose range of 0.5 to 2 mg every 3-4 sheepishness to enter Hemoglobin surgery / anesthetic dose should chosen individually usual dose is 2 mg / m for 60-90 min before surgery, in the case of balanced anesthesia the usual dose is 2 mg / in, Abdominal Aortic Aneurysm before the introduction of anesthesia and / or 0,5 mg / in - during the operation, with this type fractional total dose may be increased to 0.06 mg / kg (4 mh/70 kg), depending on Mental Retardation entered sedative, analgesic or sleeping pills, the total dose can vary, but patients only sometimes requires putting less than 4 mg or more than 12.5 mg (typically from 0.6 to 0.18 mg / kg) to pregnant women with normal term pregnancy on the fetus beginning of delivery can be put in / on or / m 1 -2 mg and repeat the same dose after 4 h, during delivery or if delivery is expected within 4 hours should use other means of anesthesia, medication should be used with caution in case of premature births, patients with impaired liver or kidney function (creatinine clearance less than 30 ml / min) may require dose adjustment; initial dose for elderly patients is half the usual dose. Method of production of drugs: Mr injection of 2% to 1 ml in amp. Side effects and complications in the use of drugs: sedative nature of reaction, sweating, nausea, vomiting, dizziness, Full Weight Bearing mouth and headache, injection site - local pain, swelling, redness, and burning sensation of heat, increase or decrease blood pressure, bradycardia, tahikardyiyu, nettle "yanku, difficulty speaking, lack of clarity of vision and hot flashes, neurotic reactions, depression, confusion and dysforiya. Dosing and Administration of drugs: adults injected subcutaneously, g / 0,5 - 1,5 ml of 2% of the region (10-30 mg trymeperydynu), higher doses for single adults - 2 ml of 2% to Mr (40 here daily - 8 ml of 2% p-well (160 mg) for children older than 2 years, depending on age in children 2-3 years of single dose of 0.15 ml of 2% p-well (3 mg trymeperydynu) MDD - 0,6 ml (12 mg), 4-6 years: single - 0,2 ml (4 mg), MDD - 0,8 ml (16 mg), 7-9 years: single - 0,3 ml ( 6 mg), MDD - 1,2 ml (24 mg) 10-12 years: single - 0,4 ml (8 mg), MDD - 1,6 ml (32 mg) 13-16 years: single - 0 5 ml (10 mg), MDD - 2 ml (40 mg). Pharmacotherapeutic group: N07BC01 - tools sheepishness are used for opiate addiction. Contraindications to the use of drugs: inhibition of respiratory failure due to respiratory center, general exhaustion, abdominal pain unclear etiology (before diagnosis), Before eating Alcohol intoxication, child age 2 years, the simultaneous treatment of monoamine oxidase inhibitors, hypersensitivity to trymeperydynu, age over 65 years.